(Q54291298)

27 May 2018

title

The effects of ox-LDL in human atherosclerosis may be mediated in part via the toll-like receptor 4 pathway. (English)

1 reference

27 May 2018

0 references

1 reference

Honglian Geng

1

1 reference

27 May 2018

Aihua Wang

2

1 reference

27 May 2018

Guanghua Rong

3

1 reference

27 May 2018

Bei Zhu

4

1 reference

27 May 2018

Yan Deng

5

1 reference

27 May 2018

Jun Chen

6

1 reference

27 May 2018

Renqian Zhong

7

1 reference

27 May 2018

publication date

14 May 2010

1 reference

27 May 2018

Molecular and Cellular Biochemistry

published in

1 reference

27 May 2018

volume

342

1 reference

27 May 2018

issue

1-2

1 reference

27 May 2018

page(s)

201-206

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s11010-010-0484-8

exact match

0 references

cites work

TLR signaling: an emerging bridge from innate immunity to atherogenesis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11010-010-0484-8

The role of chemokines in human cardiovascular pathology: enhanced biological insights

21 January 2018

1 reference

12 December 2020

Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men.

1 reference

12 December 2020

Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation

1 reference

12 December 2020

Cytokines in atherosclerosis: pathogenic and regulatory pathways

1 reference

12 December 2020

The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein

1 reference

12 December 2020

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells

1 reference

12 December 2020

Toll-like receptors are key participants in innate immune responses

1 reference

12 December 2020

RNA interference and the use of small interfering RNA to study gene function in mammalian systems

1 reference

12 December 2020

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1 reference

12 December 2020

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

1 reference

12 December 2020

Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques

1 reference

12 December 2020

Inflammation and coronary artery disease

1 reference

12 December 2020

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

1 reference

12 December 2020

A large-scale RNAi screen in human cells identifies new components of the p53 pathway

1 reference

12 December 2020

Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells

1 reference

12 December 2020

Innate immunity and atherogenesis

1 reference

12 December 2020

Inflammation in atherosclerosis

1 reference

12 December 2020

Effect of the Toll-like receptor 4 (TLR-4) variants on intima-media thickness and monocyte-derived macrophage response to LPS

1 reference

12 December 2020

Effective expression of small interfering RNA in human cells

1 reference

12 December 2020

Innate immunity, macrophage activation, and atherosclerosis

1 reference

12 December 2020

In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions

1 reference

12 December 2020

Increased expression of Toll like receptor 4 on peripheral-blood mononuclear cells in patients with coronary arteriosclerosis disease.

1 reference

12 December 2020

10.1007/S11010-010-0484-8

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018